Pasithea Therapeutics Directors Make Significant Share Buys at $0.75 Per Share

Pasithea Therapeutics Corp. [KTTA] has recently announced that Director Simon Dumesnil has acquired 33,333 shares at a price of $0.75 per share on November 28, 2025. Similarly, Director and Chief Executive Officer Tiago Marques has also purchased 33,333 shares at the same price on the same date. Furthermore, Director Lawrence Steinman has acquired 133,333 shares at $0.75 per share on November 28, 2025.